Sign In
Buy CDLX
$0.650
-0.0015 (-0.230%)
At Close: Jun 03, 2026
Cardlytics Announces Timing of Its Second Quarter 2025 Earnings Release
04:05pm, Wednesday, 23'rd Jul 2025
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that its financial results for the second quarter ending June 30, 2025 will be released on August 6, 2025, after market close.
Cardlytics Introduces New Customer Insights Dashboards Within the Cardlytics Insights Portal
09:30am, Tuesday, 15'th Jul 2025
ATLANTA--(BUSINESS WIRE)--Cardlytics Inc. (NASDAQ: CDLX) today announced the general availability of three new dashboards within the newly revamped Cardlytics Insights Portal, a unique self-service to
Cardlytics (CDLX) Shows Fast-paced Momentum But Is Still a Bargain Stock
09:51am, Friday, 04'th Jul 2025
Cardlytics (CDLX) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that
Cardlytics: Underrecognized Margin Recovery; Strong Buy Reiterated
01:46am, Monday, 26'th May 2025
We maintain our Strong Buy on Cardlytics and issue a PT of $6, despite the near-term revenue reset and slower monetization from new partners. The Amex channel is a game-changer, offering high-margin,
Cardlytics Launches Cardlytics Rewards Platform and Expands Publisher Base Beyond Financial Institutions
09:30am, Tuesday, 20'th May 2025
ATLANTA--(BUSINESS WIRE)--Cardlytics Inc. (NASDAQ: CDLX) today announced the general availability of Cardlytics Rewards Platform (CRP), a new solution that provides publishers the opportunity to enhan
Cardlytics, Inc. (CDLX) Q1 2025 Earnings Call Transcript
10:50pm, Wednesday, 07'th May 2025
Cardlytics, Inc. (NASDAQ:CDLX ) Q1 2025 Earnings Conference Call May 7, 2025 5:00 PM ET Company Participants Nick Lynton - Chief Legal and Privacy Officer Amit Gupta - Chief Executive Officer Alexis D
Cardlytics (CDLX) Reports Q1 Loss, Tops Revenue Estimates
07:51pm, Wednesday, 07'th May 2025
Cardlytics (CDLX) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.09 per share a year ago.
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 25'th Apr 2025
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that on April 24, 2025, the Compensation Committee of Cardlytics' Board of Directors granted an aggregate of 124,050 restricte
Cardlytics Announces Timing of Its First Quarter 2025 Earnings Release
04:05pm, Wednesday, 23'rd Apr 2025
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that its financial results for the first quarter ending March 31, 2025 will be released on May 7, 2025, after market close. Co
Class Action Filed Against Cardlytics, Inc. (CDLX) - March 25, 2025 Deadline to Join – Contact Levi & Korsinsky
01:30pm, Friday, 21'st Mar 2025
NEW YORK, March 21, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX) of a class action securities lawsuit.
NEW YORK, NY / ACCESS Newswire / March 21, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities law
NEW YORK , March 21, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX) of a class action securities lawsuit. CLASS DEFIN
Shareholders that lost money on Cardlytics, Inc. (CDLX) should contact The Gross Law Firm about pending Class Action - CDLX
12:56pm, Thursday, 20'th Mar 2025
NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Cardlytics, Inc. (NASDAQ: CDLX).
Lost Money on Cardlytics, Inc.(CDLX)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
05:04am, Thursday, 20'th Mar 2025
NEW YORK , March 20, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cardlytics, Inc. (NASDAQ: CDLX). Shareholders who purchased shares of CDLX during the class
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in Cardlytics Lawsuit – CDLX
01:15pm, Tuesday, 18'th Mar 2025
NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX) of a class action securities lawsuit.
